SavedAdd your journal

Journals / MN Kardiyoloji / 2003 / Cilt: 10 - Sayı: 6

A newborn with corticosteroid-induced hypertropic cardiomyopathy

Kortikosteroid kullanımına bağlı hipertrofik kardiyomiyopatili bir yenidoğan olgusu

Nazire NAÇAR
FİLİZ EKİCİ
Begüm ATASAY
Ayla GÜNLEMEZ
Semra ATALAY
Pages
477–480
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here a newborn diagnosed as steroid-induced hypertrophic cardiomyopathy will be reported and diagnosis, treatment and importance of ß-blokers in the treatment of such cases will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Steroid (dexamethasone) is widely used in various conditions in newborn period.
📊
Key Findings & Data:It is known that steroids have side effects on many systems, also on heart it may cause hypertrophic cardiomyopathy.
💡
Conclusion & Impact:Here a newborn diagnosed as steroid-induced hypertrophic cardiomyopathy will be reported and diagnosis, treatment and importance of ß-blokers in the treatment of such cases will be discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Adrenerjik beta-antagonistleri · Kardiyomiyopati · hipertrofik

Abstract

Steroid (dexamethasone) is widely used in various conditions in newborn period. It is known that steroids have side effects on many systems, also on heart it may cause hypertrophic cardiomyopathy. Here a newborn diagnosed as steroid-induced hypertrophic cardiomyopathy will be reported and diagnosis, treatment and importance of ß-blokers in the treatment of such cases will be discussed.

Özet

Yenidoğan döneminde çeşitli hastalıkların tedavisinde steroid (deksametazon) kullanımı yaygındır. Steroidlerin pekçok sistemde yan etkilerinin olduğu, kalpte de hipertrofik kardiyomiyopatiye neden olabileceği bilinmektedir. Burada yenidoğan döneminde steroide bağlı hipertrofik kardiyomiyopati tanısı konulan bir olgu sunulacak, böyle olgularda tanı, tedavi ve ß-blokerlerin tedavideki yeri tartışılacaktır.

🔖

Cite This Article

NAÇAR, N., EKİCİ, F., ATASAY, B., GÜNLEMEZ, A., ATALAY, S. (2003). A newborn with corticosteroid-induced hypertropic cardiomyopathy. MN Kardiyoloji, Cilt: 10 - Sayı: 6, 477–480. https://ajindex.com/articles/297692

References (6)

  1. Maron BJ. Hypertrophic Cardiomyopathy. In: HD Allen, EB Clark, HP Gutgesell, DJ Driscoll (eds). MOSS and ADAMS' Heart Disease in Infants, Children and Adolescents (6th ed). Philadelphia, Lippincott Williams & Wilkins 2001:1167-86.
  2. Tutar HE, Arsan S, Kuzu I, Atalay S, Atasay B, Gençgönül H. Dismorfik bulguları olan bir yenidoğanda hipertrofik kardiyomiyo- pati: Noonan sendromu. Türk Kardiyol Dern Arş 1999; 27:59-62.
  3. Val'kovich El, Molchanova W, Davydova MK, Davydova OK. Change in the myocardium of fetuses and newborn infants as a result of hypoxia. Arkh Anat Gistol Embriol 1986; 90:35-9.
  4. Miranda-Mallea J, Perez-Verdu J, Gasco-Lacalle B, Saez- Palacias JM, Femandez-Gilino C, Izquierdo-Macian I. Hyper­ trophic cardiomyopathy in preterm infants treated with dexamet- hasone. Eur J Pediatr 1997; 156:394-6. Ng PC. The effectiveness and side effects of dexamethaso- ne in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 1993-68:330-6. Alpert R. Steroid-induced hypertrophic cardiomyopathy in an infant. Pediatr Cardiol 1984; 5:117-8.
  5. Werner JC, Sicord RE, Hansen TWR, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexa- methasone therapy for bronchopulmonary dysplasia. J Pediatr 1992;120:286-91.
  6. Villa Alcazar M, Pellicer Martinez A, Burguenos Valoros M, Quero Jimenez J. Miocardiopatia hipertrofica en un recien naci- do de bajo peso tratado can dexametasona. An Esp Pediatr.1996;-44:393-4.